BioLineRx Ltd. (BLRX)
2.80
-0.01
(-0.36%)
USD |
NASDAQ |
Aug 24, 16:00
2.80
0.00 (0.00%)
After-Hours: 20:00
BioLineRx Total Liabilities (Quarterly) : 17.96M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 17.96M |
| December 31, 2025 | 17.56M |
| September 30, 2025 | 20.27M |
| June 30, 2025 | 23.20M |
| March 31, 2025 | 22.65M |
| December 31, 2024 | 25.44M |
| September 30, 2024 | 44.24M |
| June 30, 2024 | 50.62M |
| March 31, 2024 | 38.54M |
| December 31, 2023 | 50.70M |
| September 30, 2023 | 39.72M |
| June 30, 2023 | 37.88M |
| March 31, 2023 | 29.53M |
| December 31, 2022 | 25.54M |
| September 30, 2022 | 26.15M |
| June 30, 2022 | 11.27M |
| March 31, 2022 | 11.36M |
| December 31, 2021 | 13.30M |
| September 30, 2021 | 16.00M |
| June 30, 2021 | 17.44M |
| March 31, 2021 | 18.95M |
| December 31, 2020 | 25.26M |
| September 30, 2020 | 21.23M |
| June 30, 2020 | 23.76M |
| March 31, 2020 | 18.66M |
| Date | Value |
|---|---|
| December 31, 2019 | 20.19M |
| September 30, 2019 | 18.03M |
| June 30, 2019 | 20.18M |
| March 31, 2019 | 21.71M |
| December 31, 2018 | 14.91M |
| September 30, 2018 | 5.815M |
| June 30, 2018 | 6.027M |
| March 31, 2018 | 7.053M |
| December 31, 2017 | 8.084M |
| September 30, 2017 | 7.094M |
| June 30, 2017 | 5.613M |
| March 31, 2017 | 5.389M |
| December 31, 2016 | 3.908M |
| September 30, 2016 | 3.669M |
| June 30, 2016 | 3.116M |
| March 31, 2016 | 2.939M |
| December 31, 2015 | 3.692M |
| September 30, 2015 | 4.36M |
| June 30, 2015 | 6.539M |
| March 31, 2015 | 5.685M |
| December 31, 2014 | 4.403M |
| September 30, 2014 | 4.094M |
| June 30, 2014 | 5.756M |
| March 31, 2014 | 6.769M |
| December 31, 2013 | 8.292M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 113.60M |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 2.079M |
| Revium Recovery, Inc. | 0.693M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 38.80M |
| Shareholders Equity (Quarterly) | 16.67M |
| Debt to Equity Ratio | 0.544 |
| Current Ratio | 1.584 |
| Net Debt Paydown Yield | 11.93% |